Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Puma Biotechnology Inc (NASDAQ: PBYI) closed the day trading at $2.65 up 4.33% from the previous closing price of $2.54. In other words, the price has increased by $4.33 from its previous closing price. On the day, 0.67 million shares were traded. PBYI stock price reached its highest trading level at $2.7 during the session, while it also had its lowest trading level at $2.45.
Ratios:
For a better understanding of PBYI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.91. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 2.03 whereas as Long-Term Debt/Eq ratio is at 0.99.
Goldman Downgraded its Neutral to Sell on October 08, 2019, whereas the target price for the stock was revised from $24 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’24 when MILLER MICHAEL PATRICK sold 23,358 shares for $3.49 per share. The transaction valued at 81,466 led to the insider holds 47,000 shares of the business.
MILLER MICHAEL PATRICK bought 23,358 shares of PBYI for $87,826 on Aug 12 ’24. On Jul 17 ’24, another insider, NOUGUES MAXIMO F, who serves as the Chief Financial Officer of the company, sold 4,156 shares for $3.70 each. As a result, the insider received 15,382 and left with 162,522 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBYI now has a Market Capitalization of 129973760 and an Enterprise Value of 131728816. As of this moment, Puma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.49, and their Forward P/E ratio for the next fiscal year is 13.47. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.59 while its Price-to-Book (P/B) ratio in mrq is 2.65. Its current Enterprise Value per Revenue stands at 0.601 whereas that against EBITDA is 4.236.
Stock Price History:
Over the past 52 weeks, PBYI has reached a high of $7.73, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is -20.02%, while the 200-Day Moving Average is calculated to be -39.87%.
Shares Statistics:
Over the past 3-months, PBYI traded about 464.53K shares per day on average, while over the past 10 days, PBYI traded about 505740 shares per day. A total of 47.65M shares are outstanding, with a floating share count of 34.93M. Insiders hold about 28.78% of the company’s shares, while institutions hold 56.92% stake in the company. Shares short for PBYI as of 1722384000 were 3822121 with a Short Ratio of 8.23, compared to 1719532800 on 2928713. Therefore, it implies a Short% of Shares Outstanding of 3822121 and a Short% of Float of 9.1800004.
